Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

The National Cancer Institute

Apr 2007
The National Cancer Institute has awarded a three-year, $1.9 million grant to Lucid Inc. of Rochester, N.Y., to evaluate the company’s VivaScope in vivo confocal microscopy technology for the diagnosis of pigmented lesions. The study will involve approximately 600 patients in New York and California. The instrument is a noninvasive skin imaging tool with cellular resolution that may in the future eliminate the need for skin biopsy.

Biophotonicsbiopsyconfocal microscopy technologyMicroscopyNews & FeaturesThe National Cancer Institute

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.